what is glp-1 agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review A Comprehensive Review of the
Description
About 90% of those who received the 10- or 15-mg dose achieved 5% weight loss
Drug Discov Today
doi: 10.1007/s00125-016-3952-1 119 ArmstrongMJAdamsLACanbayASynWK
Before Zepbound Existed: Mounjaro was the only tirzepatide option available from May 2022 until November 2023 when Zepbound received FDA approval for weight loss
It may be more suitable for those who consume fatty foods
Another example is a potential interaction between dexamethasone and GLP1RAs [34], yielding false positive results of dexamethasone-suppression test
